220 related articles for article (PubMed ID: 9138348)
1. [Medical treatment of colorectal cancer].
Díaz-Cantón EA; Pazdur R
Medicina (B Aires); 1996; 56(4):414-22. PubMed ID: 9138348
[TBL] [Abstract][Full Text] [Related]
2. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
3. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
Benson AB
Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
[TBL] [Abstract][Full Text] [Related]
4. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
Bokemeyer C; Hartmann JT; Kanz L
Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for colon and rectal cancer.
Ratkin GA
Am Fam Physician; 1997 May; 55(7):2487-92, 2495-6. PubMed ID: 9166147
[TBL] [Abstract][Full Text] [Related]
6. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
Fietkau R; Zettl H; Klöcking S; Kundt G
Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
[TBL] [Abstract][Full Text] [Related]
7. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
8. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
9. Is there a role for adjuvant therapy in bowel cancer?
Marsh JC
J Clin Gastroenterol; 1994 Apr; 18(3):184-8. PubMed ID: 8034911
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary treatment of colorectal cancer in New Zealand: survival rates from 1997-2002.
Keating J; Yong D; Cutler G; Johnston J
N Z Med J; 2006 Sep; 119(1242):U2238. PubMed ID: 16998579
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer.
Neilan BA
Clin Geriatr Med; 1987 Nov; 3(4):625-35. PubMed ID: 3315160
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
13. [Current status of adjuvant therapy in patients with colorectal cancer: report and commentary on the Consensus Conference, 16-18 April 1990, National Cancer Institute, Bethesda, Maryland].
Steger G; Jakesz R
Wien Klin Wochenschr; 1991; 103(4):117-21. PubMed ID: 1710398
[TBL] [Abstract][Full Text] [Related]
14. NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer Network.
Engstrom PF; Benson AB; Cohen A; Doroshow J; Kiel K; Niederhuber J; Roh M; Tempero M
Oncology (Williston Park); 1996 Nov; 10(11 Suppl):140-75. PubMed ID: 8953601
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
16. [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases].
Xu JM; Qin XY; Zhong YS; Wei Y; Fan J; Zhou J; Qin LX; Wang JH; Yan ZP; Cheng JM; Wu ZH
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):54-7. PubMed ID: 17575696
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Kodaira S; Shatari T; Nozawa K
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
[TBL] [Abstract][Full Text] [Related]
18. Current protocols and outcomes for colonic cancer: why do we fail?
Guleserian KJ; Bland KI
Surg Oncol Clin N Am; 2000 Oct; 9(4):725-38; discussion 739-40. PubMed ID: 11008237
[TBL] [Abstract][Full Text] [Related]
19. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
20. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
